AllAnalyst Report
Morningstar•October 28, 2020
Morningstar•October 28, 2020VAR: No Changes to Varian Following Release of Year-End Results; Acquisition by Healthineers on Target
Summary
Varian Medical Systems designs, manufactures, and sells radiation technology for use in two business segments: oncology systems and proton therapy. The Americas account for the largest portion of revenue (47%), follo
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeActions
Download Full ReportRelated Reports
- Analyst Report: Bristol-Myers Squibb CompanyApr 25, 2024 •
BMY
- Analyst Report: Core Laboratories Inc.Apr 25, 2024 •
CLB
- Analyst Report: Equinor ASAApr 25, 2024 •
EQNR
- Analyst Report: Pegasystems Inc.Apr 25, 2024 •
PEGA
- Analyst Report: Teradyne, Inc.Apr 25, 2024 •
TER
Analyst Profile
Alex Morozov
Regional DirectorAlex Morozov, CFA, is director of European equity research for Morningstar Holland BV, a wholly owned subsidiary of Morningstar, Inc. He leads a team of equity analysts based in Europe who cover European and global companies across all major sectors of the economy.Before assuming his current role in 2014, Morozov was head of global healthcare equity research. Previously, he was a senior equity analyst, covering the medical instruments, life sciences, and diagnostics industries. Before joining Morningstar in 2006, Morozov worked in the insurance industry.Morozov holds a bachelor’s degree in finance, with a minor in mathematics, from the University of Missouri. He also holds the Chartered Financial Analyst® designation.